Sort
48,018 grants matching “immunotherapy”
Molecular Mechanisms and Treatment Of Autoimmunity In Man And Animal Models
$985,870Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Delaware Christiana Care CCOP
$985,765Christiana Care Health Services, Inc. · U10 · FY2004 · CA
Elucidation and targeting of paracrine cascades in PDAC
$985,518Kenneth P Olive · Columbia University Health Sciences · U01 · FY2022 · CA
Elucidation and targeting of paracrine cascades in PDAC
$985,518Kenneth P Olive · Columbia University Health Sciences · U01 · FY2023 · CA
Elucidation and targeting of paracrine cascades in PDAC
$985,518Kenneth P Olive · Columbia University Health Sciences · U01 · FY2025 · CA
Adoptive T cell Therapy for Pediatric Leukemia
$985,195Terry Fry · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Programming T Cell Fates for Therapeutic Use
$984,972Luca Gattinoni · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
IntellipulseTM Platform Technology for Effective Delivery of Therapeutic Agents
$984,830Gary Strange · Ef Therapeutics Corp. · R44 · FY2025 · CA
Metabolic regulation of T cell effector function and anti-tumor immunotherapy
$984,739Naomi Taylor · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Commercialization of Safe and Effective Locoregional Head and Neck Cancer Therapy
$984,664Manijeh N Goldberg · Privo Technologies, Llc · R44 · FY2023 · DE
Biology and Therapy of T Cell Depletion
$984,566Crystal L Mackall · Clinical Sciences · Z01 · FY2007 · CA
Immunobiology and Immunotherapy of Pediatric Tumors
$984,566Crystal L. Mackall · Clinical Sciences · Z01 · FY2007 · CA
Integrated assays of single-cell dynamics and molecular phenotype for cell therapy manufacturing
$984,242Rebecca L Berdeaux · Cellchorus Inc. · R44 · FY2025 · TR
The role of clonal hematopoiesis in the development and therapy of myeloid malignancies
$984,165Benjamin Levine Ebert · Dana-Farber Cancer Inst · R35 · FY2023 · CA
The role of clonal hematopoiesis in the development and therapy of myeloid malignancies
$984,165Benjamin Levine Ebert · Dana-Farber Cancer Inst · R35 · FY2022 · CA
Hematopoietic Chimerism after Stem Cell Allografts
$984,084Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2019 · CA
Metabolic reprogramming of the tumor microenvironment and therapy resistance
$984,000Ernst Lengyel · University Of Chicago · R35 · FY2025 · CA
Los Angeles Pediatric AIDS Clinical Trials Unit
$983,776University Of California Los Angeles · U01 · FY2004 · AI
Project 2: Interrogating immuno-metabolic programs using a novel Flow Cytometry based assay to reveal novel T cell subsets in SARS-CoV-2 infected patients
$983,246Jonathan D Powell · Johns Hopkins University · U54 · FY2020 · CA
Molecular Pathogenesis of Neoplasia
$983,208Richard Youle · National Institute Of Neurological Disorders And Stroke · ZIA · FY2018 · NS
Development of new passive immunization strategies for anthrax
$983,096Arturo Casadevall · Columbia University Health Sciences · U54 · FY2012 · AI
Clinical Analysis Of Disorders Of Hearing And Balance
$982,665Carmen Crowell Brewer · National Institute On Deafness And Other Communication Disorders · ZIA · FY2013 · DC
A Therapeutic Vaccine for Chronic Hepatitis B
$982,569David R. Milich · Vlp Biotech, Inc. · R44 · FY2013 · AI
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
$982,420Megan Sykes · Columbia University Health Sciences · U01 · FY2019 · DK
Humanized Monoclonal Antibody to Treat Acinetobacter Infections
$982,415Khalid Islam · Biological Anti-Infective Medicines, Llc · R42 · FY2016 · AI